(Q67270678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

OPC-8212 in the treatment of congestive heart failure: results of a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

congestive heart failure

1 reference

S H Kubo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

T S Rector

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

J E Strobeck

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

J N Cohn

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

publication date

1 December 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Drugs and Therapy

11 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

653-660

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.

11 September 2019

cites work

1 reference

12 December 2020

Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Electrophysiologic effects of milrinone in patients with congestive heart failure.

1 reference

12 December 2020

A simplified radiometric assay for plasma norepinephrine and epinephrine

1 reference

12 December 2020

Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

1 reference

12 December 2020

Cardiotonic activity of a new inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), in the dog with and without beta-blocker and Ca++-antagonist pretreatment.

1 reference

12 December 2020

Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure

1 reference

12 December 2020

Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart

1 reference

12 December 2020

Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle

1 reference

12 December 2020

Oral OPC-8212 for the treatment of congestive heart failure: hemodynamic improvement and increased exercise capacity

1 reference

12 December 2020

Survival in congestive heart failure during treatment with drugs with positive inotropic actions.

1 reference

12 December 2020

Evidence for possible increase of sodium channel open time and involvement of Na/Ca exchange by a new positive inotropic drug: OPC-8212.

1 reference

12 December 2020

Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias

1 reference

12 December 2020

Hemodynamic and electrophysiological effects of a novel positive inotropic drug, OPC-8212, in normal and "failing" guinea pig heart preparations

1 reference

12 December 2020

Effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212) and its solvent sulfolane on isolated heart preparations of the rat, guinea pig, and dog.

1 reference

12 December 2020

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial

1 reference

12 December 2020

Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart failure

1 reference

12 December 2020

Effects of OPC-8212, a new positive inotropic agent, on canine ventricular arrhythmias

1 reference

12 December 2020

Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle

1 reference

12 December 2020

Acute dose range study of milrinone in congestive heart failure.

1 reference

12 December 2020

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure

1 reference

12 December 2020

Membrane current changes responsible for the positive inotropic effect of OPC-8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heart

1 reference

12 December 2020

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00054205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3154640%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference